Stay updated on AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Sign up to get notified when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.

Latest updates to the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedMajor changes: updated operating status notice and version to v3.2.0; removal of v3.1.0.SummaryDifference13%
- Check23 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.3%
- Check38 days agoChange DetectedPage version bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed. No substantive content changes were detected.SummaryDifference0.8%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.8%
- Check52 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and previous state and country references.SummaryDifference9%
- Check67 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%
Stay in the know with updates to AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.